Start A New Thread

Rate Johnson & Johnson

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×
Jobs for Johnson & Johnson

 

Medtech[y] Guarantee

COMPANONYMOUS

Our Promise to you - Company & Hospital boards are always anonymous

Cordis

3 days ago

12 replies

What a sad for the tenured folks at Cordis who will end up retiring instead of fighting Cardinal on sales strategy. We were fed the Credo and even though we were warned, JNJ destroyed another device company that had so much promise. Cardinal is not a bad company, but they aren't interested in developing cutting edge products so my decision is made.

J&J Hid Risperdal Risks of Boy Breast Development, Jury Told

1 week ago

5 replies

For those keeping track of the relationships between the pharmaceutical industry and former FDA staffers, Johnson & Johnson added Mark McClellan, who served as FDA commissioner from 2002 to 2004 and then headed the Centers for Medicaid & Medicare Services from 2004 to 2006, to its board of directors. At least Former FDA commissioner David Kessler understands what conflict of interest means and testified against Johnson & Johnson and for the Risperdal victim at trial.
www.buycot…

BOYCOTT Johnson & Johnson hired exFDA Commissioner. on Buycott

Buycott helps you to organize your everyday consumer spending so that it reflects your principles.

JNJ Wants $5B from Boston Scientific

3 months ago

1 reply

My favorite part of the article:

  • J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of yesterday had a market capitalization of $17.8 billion

Johnson & Johnson Primary Care Position

5 months ago

2 replies

You will be lucky to hit 100k total but you will have to negotiate to make that happen. The best advice I can give is go speciality. You don't want to be stuck in PC.

JNJ 3rd Quarter Earnings

5 months ago

4 replies

Summary

  • Johnson & Johnson has increased US pharmaceutical sales by over 30% over the last 12 months.

  • The company is seeing lackluster growth in the US in both its consumer division and medical devices and diagnostics.

  • Johnson & Johnson is not capitalizing on macro economic trends that are driving growth for competitors in emerging markets.

seekingalpha.com/article/2560205-johnson-and-johnson-q3-results-show-rapid-us-pharmaceutical-growth-but-little-else

JNJ, the Pinnacle of Awesomeness

6 months ago

1 reply

This is pretty sad. How about executives face jail time instead of paying a fine to get out of messing with someone's life.

"Unit ran amok marketing Pinnacle"

J&J Unit Ran ‘Amok’ Marketing Pinnacle Hips, Jury Told

Johnson & Johnson’s bid to convince doctors the metal-on-metal version of its Pinnacle hip implants were safe amounted to “marketing run amok,” a lawyer told jurors in the first case over the devices to go to trial.

Credo, huh?

6 months ago

10 replies

Good article. The FDA probably knew but only came clean because of the WSJ.

JNJ Eyes Acquisitions

7 months ago

13 replies

Interesting. What options would they have in cardiology or cardiothoracic surgery?

Great Stock!

8 months ago

4 replies

I think that is the goal. I heard JNJ also has an ownership in this therapy. Pretty smart if you ask me.

image

Loading...

Load More

'